...
【24h】

Can Osteopenia Induce Residual Dizziness After Treatment of Benign Paroxysmal Positional Vertigo?

机译:骨质增生症可以在治疗良性阵发性位置眩晕后诱导残留的头晕吗?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective:This study aimed to determine whether there is an association between osteopenia and residual dizziness after successful treatment of benign paroxysmal positional vertigo (BPPV).Methods:In all, 62 patients with canalolithiasis-type BPPV were included in the study. Patients were divided into two groups according to the presence of residual dizziness after resolution of BPPV. Univariate and multivariate analyses were performed to determine the factors associated with residual dizziness. Patients were analyzed based on age, sex, affected semicircular canal, affected side, BPPV duration, and presence of hypertension, diabetes mellitus, hyperlipidemia, and osteopenia.Results:In univariate analysis, BPPV duration and osteopenia showed a relatively significant association (p<0.20) with the development of residual dizziness. On subsequent multivariate analysis using these factors, osteopenia remained a statistically significant factor in association with residual dizziness (p=0.012, odds ratio, 9.916).Conclusion:Osteopenia is associated with the development of residual dizziness. BPPV patients with osteopenia more frequently suffer from residual dizziness after successful treatment of BPPV than those without osteopenia.
机译:目的:该研究旨在确定骨质血症和成功治疗后骨质细胞和残留头晕之间是否存在关联的良性阵发性位置眩晕(BPPV)。方法:在所有情况下,62名可聚氨酯型BPPV患者纳入该研究。根据分辨BPPV后,患者根据残留头晕的存在分为两组。进行单变量和多变量分析以确定与残留头晕相关的因素。基于年龄,性别,影响半圆形管,受影响的侧面,BPPV持续时间和高血压,糖尿病,高脂血症和骨质松的存在分析患者。结果:在单变量分析中,BPPV持续时间和骨质增长表现出相对重要的关联(P < 0.20)随着残留头晕的发展。在使用这些因素的随后多变量分析中,骨质增生仍然与残余头晕相关(P = 0.012,差距,9.916)。结论:骨内血与残留头晕的发展有关。 BPPV患者骨质增强症患者在成功治疗BPPV后更频繁地患有残留的头晕而不是没有骨质增生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号